Automatic Quantification of Local Plaque Thickness Differences as Assessed by Serial Coronary Computed Tomography Angiography Using Scan-Quality-Based Vessel-Specific Thresholds [0.03%]
基于扫描质量的血管特异性阈值下序列冠状动脉CT造影评估下的局部斑块厚度差异的自动量化
Finn Y van Driest,Alexander Broersen,Rob J van der Geest et al.
Finn Y van Driest et al.
Introduction: The use of serial coronary computed tomography angiography (CCTA) allows for the early assessment of coronary plaque progression, a crucial factor in averting major adverse cardiac events (MACEs). Traditiona...
Impact of Access Site on Periprocedural Bleeding and Cerebral and Coronary Events in High-Bleeding-Risk Percutaneous Coronary Intervention: Findings from the RIVA-PCI Trial [0.03%]
入路部位对高出血风险经皮冠状动脉介入治疗术 peri-procedure 出血及脑血管和冠脉事件的影响——RIVA-PCI 研究结果
Martin Borlich,Uwe Zeymer,Harm Wienbergen et al.
Martin Borlich et al.
Introduction: The preference for using transradial access (TRA) over transfemoral access (TFA) in patients requiring percutaneous coronary intervention (PCI) is based on evidence suggesting that TRA is associated with les...
Dual-Pathway Inhibition with Rivaroxaban and Low-Dose Aspirin Does Not Alter Immune Cell Responsiveness and Distribution in Patients with Coronary Artery Disease [0.03%]
利伐沙班联合小剂量阿司匹林双通道抑制并未改变冠心病患者免疫细胞的反应性和分布状态
Laszlo A Groh,Loes H Willems,Paula Fintelman et al.
Laszlo A Groh et al.
Introduction: Cardiovascular diseases (CVD) are the leading cause of death globally. Inflammation is an important driver of CVD where tissue damage may lead to the formation of deadly thrombi. Therefore, antithrombotic dr...
Xuejing Yu
Xuejing Yu
Myocardial infarction (MI) is a leading cause of death globally. Due to limited cardiac regeneration, infarcted myocardial tissue is gradually replaced by cardiac fibrosis, causing cardiac dysfunction, arrhythmia, aneurysm, free wall ruptur...
Podcast on Self-administered Intranasal Etripamil for Symptomatic Paroxysmal Supraventricular Tachycardia: The RAPID Trial [0.03%]
关于自服经鼻给药乙梯帕米治疗阵发性室上性心动过速的Ⅱ期研究（RAPID试验）播客
Bruce S Stambler,James E Ip
Bruce S Stambler
Paroxysmal supraventricular tachycardia (PSVT) is commonly seen in clinical practice and represents a significant burden to the healthcare system and to patients. First-line treatments include calcium channel blockers (CCB), although they a...
Cardiovascular Compatibility of Proton Pump Inhibitors: Practice Recommendations [0.03%]
质子泵抑制剂的心血管安全性：实践推荐意见
Jamshed Dalal,Anjan Lal Dutta,Jagdish Hiremath et al.
Jamshed Dalal et al.
This manuscript aims to critically evaluate the current evidence regarding adverse cardiovascular effects associated with proton pump inhibitors (PPIs) in patients with coronary artery disease (CAD). It also provides guidance for the select...
Takashi Nagasaka,Mamoo Nakamura
Takashi Nagasaka
Atrial fibrillation (AF) is the most common cardiac arrhythmia and the cause of thromboembolic events in elderly patients worldwide. AF is associated with a significantly increased risk of morbidity and mortality due to cardiac emboli, prim...
Comparative Effectiveness of Various Radiofrequency Ablation Catheters in the Ablation of Typical Atrial Flutter [0.03%]
不同类型射频消融导管行典型房颤消融的疗效比较
Asher Gorantla,Mahmoud Alsaiqali,Jonathan Francois et al.
Asher Gorantla et al.
Introduction: Although ablation of typical atrial flutter (AFL) can be easily achieved with radiofrequency energy (RF), no studies compare the effectiveness of different ablation catheters. Our study aimed to compare the ...
Idarucizumab for Emergency Reversal of the Anticoagulant Effects of Dabigatran: Final Results of a Japanese Postmarketing Surveillance Study [0.03%]
idarucizumab紧急逆转达比加群抗凝作用的日本上市后监测研究最终结果分析
Masahiro Yasaka,Hiroyuki Yokota,Michiyasu Suzuki et al.
Masahiro Yasaka et al.
Introduction: Idarucizumab, a monoclonal antibody fragment that rapidly reverses the anticoagulant effects of dabigatran, was approved in Japan in September 2016, at which time an all-case, postmarketing surveillance (PMS...
Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study [0.03%]
真实世界中依洛尤单抗在五国他汀耐受不良的高胆固醇患者中的使用情况：ZERBINI研究分析
Milan Gupta,Rajvi J Wani,Khalid Al Faraidy et al.
Milan Gupta et al.
Introduction: This study characterizes patients receiving evolocumab in clinical practice and assesses treatment effectiveness, safety and persistence outcomes across five countries. ...